Inhibition of melanogenic activity by 4,4′-dihydroxybiphenyl in melanoma cells

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 1, 2006, Pages 14-16

  No, Jae Kyung ^a   Kim, You Jung ^b   Lee, Jun Sik ^a   Chung, Hae Young ^a  

^a Pusan National University   (South Korea)

^b Pusan Women's University   (South Korea)

Author keywords

4,4 dihydroxybiphenyl; Cyclic AMP; Microphthalmia transcription factor; Protein kinase A; Reduced glutathione; Tyrosinase

Indexed keywords

4,4' DIHYDROXYBIPHENYL; BIPHENYL DERIVATIVE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION; MELANOGENESIS; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

BIPHENYL COMPOUNDS; BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION; GLUTATHIONE; HUMANS; MELANINS; MELANOMA, EXPERIMENTAL; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; OXIDATION-REDUCTION;

EID: 29844441290     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.14     Document Type: Article

References (16)

1. Yamamura T., Onishi J., Nishiyama T., Arch. Dermatol. Res., 294, 349-354 (2002).
2. Marmol V. D., Solano F., Sels A., Huez G., Libert A., Lejeune F., Ghanem G., J. Invest. Dermatol., 101, 871-874 (1993).
3. Bohm M., Luger T. A., Hautarzt., 55, 436-445 (2004).
4. Hoganson G. E., Ledwitz-Rigby F., Davidson R. L., Fuller B. B., Somat. Cell Mol. Genet., 15, 255-263 (1989).
5. Bertolotto C., Abbe P., Hemesath T. J., Bille K., Fisher D. E., Ortonne J. P., Ballotti R., J. Cell Biol., 142, 827-835 (1998).
6. Kirschner L. S., Carney J. A., Pack S. D., Taymans S. E., Giatzakis C., Cho Y. S., Cho-Chung Y. S., Stratakis C. A., Nat. Genet., 26, 89-92 (2000).
7. Kim Y. J., No J. K., Lee J. H., Chung H. Y., Biol. Pharm. Bull., 28, 323-327 (2005).
8. Pandey A., Katiyar S. S., J. Enzyme Inhib., 11, 141-149 (1996).
9. Yukitake J., Otake H., Inoue S., Wakamatsu K., Olivares C., Solano F., Hasegawa K., Ito S., Melanoma Res., 13, 603-609 (2003).
10. Imokawa G., J. Invest. Dermatol., 93, 100-107 (1989).
11. Meister A., Science, 220, 472-477 (1983).
12. Mun Y. J., Lee S. W., Jeong H. W., Lee K. G., Kim J. H., Woo W. H., Biol. Pharm. Bull., 27, 806-809 (2004).
13. Busca R., Bertolotto C., Ortonne J. P., Ballotti R., J. Biol. Chem., 27, 31824-31830 (1996).
14. Schwahn D. J., Xu W., Herrin A. B., Bales E. S., Medrano E. E., Pigment. Cell Res., 14, 32-39 (2001).
15. Price E. R., Horstmann M. A., Wells A. G., Weilbaecher K. N., Takemoto C. M., Landis M. W., Fisher D. E., J. Biol. Chem., 273, 33042-33047 (1998).
16. Kim D. S., Park S. H., Kwon S. B., Li K., Youn S. W., Park K. C., Arch. Pharm. Res., 27, 334-339 (2004).